Soleno Therapeutics, Inc. (SLNO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.1794 |
| Open | 0.1887 |
| Bid | 0.1800 x 1000 |
| Ask | 0.1880 x 3200 |
| Day's range | 0.1700 - 0.1940 |
| 52-week range | 0.1300 - 1.6700 |
| Volume | |
| Avg. volume | 786,014 |
| Market cap | 14.684M |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.
- Zacks
Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug
The FDA accepts Regulus' (RGLS) IND application for RGLS8429 to treat autosomal dominant polycystic kidney disease. The company plans to begin a phase I study in second-quarter 2022. Stock up.
- Zacks
Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y
Catalyst's (CPRX) first-quarter 2022 earnings miss estimates while revenues meet the same.
© 2022 Yahoo. All rights reserved.
